Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-011832

Chief Executive Officer sold 356,546 shares at an average $157.99 ($56,330,724)

  • Chief Executive Officer acquired 208,708 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Leproust Emily M. · Chief Executive Officer

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-17 Exercise or conversion : show line 1 in the form 10b5-1 +133,269 $26.66 $3,552,952 901,696 D
2026-09-17 Exercise or conversion : show line 2 in the form 10b5-1 +75,439 $8.82 $665,372 977,135 D
2026-09-17 Sale : show line 3 in the form 10b5-1 −2,440 $151.46 $369,566 974,695 D
2026-09-17 Sale : show line 4 in the form 10b5-1 −6,644 $152.21 $1,011,291 968,051 D
2026-09-17 Sale : show line 5 in the form 10b5-1 −3,399 $153.40 $521,417 964,652 D
2026-09-17 Sale : show line 6 in the form 10b5-1 −4,175 $154.17 $643,661 960,477 D
2026-09-17 Sale : show line 7 in the form 10b5-1 −13,378 $155.46 $2,079,701 947,099 D
2026-09-17 Sale : show line 8 in the form 10b5-1 −9,097 $156.47 $1,423,384 938,002 D
Open-market sales · 356,546 sh · avg $157.99 · $56,330,724

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-17 Exercise or conversion : show line 16 in the form 10b5-1 Employee Stock Option (right to buy) −75,439 0 D
2026-09-17 Exercise or conversion : show line 17 in the form 10b5-1 Employee Stock Option (right to buy) −133,269 0 D
Loading xslF345X06/marketforms-74024.xml…